Washington, DC 20057
counterfeiting, counterfeit goods, safety, intellectual property, public health
Arab American, health, minority status, health disparity
albania, pharmaceuticals, drugs, regulation, corruption
counterfeit goods, counterfeit pharmaceuticals, medicines, drugs
policy, tariffs, trade barriers, essential drugs, essential medicines
IP, Criminal Law, Public Health, counterfeit goods, drugs, medical products, intellectual property
Albania, procurement law, corruption, pharmaceuticals
Cookies are used by this site. To decline or learn more, visit our Cookies page.
This page was processed by apollobot1 in 0.188 seconds
We'd like to ask you to provide feedback on your experience with SSRN today. Your feedback will be used to enhance the site in the future.
Would you be willing to answer a few questions when you leave our site?
Yes, I'm willing to take part in a survey
No, thank you